跳到正文

NAMSW — Newamsterdam Pharma Company 机构持仓 · 2026年Q2

谁持有 Newamsterdam Pharma Company(NAMSW)?2026年Q2(报告期截至 2026-06-30)共有 14 家机构在 SEC 13F 申报中报告持有,合计 4,591.51 万美元。前几大持有机构:Ikarian Capital, LLC(1,360.00 万美元)、Frazier Life Sciences Management, L.P.(1,070.00 万美元)、Ra Capital Management, L.P.(710.00 万美元)。

排名机构市值股数变动
1Ikarian Capital, LLC$13.6M400,000新建仓
2Frazier Life Sciences Management, L.P.$10.7M500,333持平
3RA CAPITAL MANAGEMENT, L.P.$7.1M333,333持平
4Affinity Asset Advisors, LLC$5.3M245,000持平
5Bain Capital Life Sciences Investors, LLC$2.1M99,999持平
6DEERFIELD MANAGEMENT COMPANY, L.P.$2.0M92,787持平
7MILLENNIUM MANAGEMENT LLC$1.6M75,000持平
8SIMPLEX TRADING, LLC$1.5M45,400减持
9IMC-Chicago, LLC$1.1M32,700增持
10ARISTEIA CAPITAL, L.L.C.$343,37715,708持平
11WOLVERINE ASSET MANAGEMENT LLC$318,94714,925增持
12Vestcor Inc$143,0006,666持平
13GROUP ONE TRADING LLC$16,945500持平
14UBS Group AG$8,523443增持

来源:SEC 13F 申报文件 · 截至 2026-06-30